亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

A systematic review and meta-analysis of the clinical effectiveness and safety of unilateral versus bilateral iliac branch devices for aortoiliac and iliac artery aneurysms

医学 髂内动脉 髂动脉 外科 髂总动脉 荟萃分析 髂外动脉 放射科 内科学
作者
Zhanjiang Cao,Rongrong Zhu,Amir Ghaffarian,Weiwei Wu,Chengxin Weng,Xiyang Chen,Sherene Shalhub,Benjamin W. Starnes,Wayne W. Zhang
出处
期刊:Journal of Vascular Surgery [Elsevier BV]
卷期号:76 (4): 1089-1098.e8 被引量:18
标识
DOI:10.1016/j.jvs.2022.03.005
摘要

ObjectiveIliac branch devices (IBDs) have been used in the treatment of aortoiliac and isolated iliac artery aneurysms. The aim of this systematic review and meta-analysis was to investigate the clinical effectiveness and safety of IBDs.MethodsA systematic review of the literature was conducted by identifying studies in the Medline, EMBASE, and Cochrane databases regarding the outcomes of IBDs in aortoiliac or isolated iliac artery aneurysms between May 2006 and December 2020. Individual studies were evaluated for the following major outcomes: technical success, 30-day mortality, primary patency, endoleak, reintervention, and rates of pelvic ischemia. Furthermore, subgroup meta-analyses were performed to compare the pelvic ischemic events in patients with bilateral IBDs, unilateral IBDs, and bilateral internal iliac artery (IIA) embolization/coverage.ResultsForty-five studies with a total of 2736 patients undergoing unilateral or bilateral IBDs met inclusion criteria and were included in the analysis. The pooled technical success rate of IBDs was 98.0% (confidence interval [CI]: 97.3%-98.7%). After IBD treatment, the 30-day mortality rate was 0.4% (CI: 0.07%-0.70%); 30-day patency was 98.4% (CI: 97.7%-99.0%); buttock claudication developed in 1.84% (CI: 1.26%-2.41%); and endoleak occurred in 11.9% (CI: 9.2%-14.7%) and reintervention in 7.6% (CI: 5.65%-9.58%). Furthermore, in patients with bilateral iliac artery involvement, the pooled estimate rates of buttock claudication were 0.7% in the bilateral IBD group, 7.9% in unilateral IBD with contralateral IIA embolization patients, and 33.8% in bilateral IIA embolization/coverage patients, which were statistically significant among the three groups. Sexual dysfunction was 5.0% in the bilateral IIA occlusion group, which was significantly higher than that in IBD groups.ConclusionsThe utilization of IBDs in the treatment of aortoiliac or isolated iliac artery aneurysms is associated with high technical success rates as well as low incidences of pelvic ischemia. The risk of postoperative buttock claudication can be further decreased with both IIA preservation if patients are anatomically suitable for bilateral IBDs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
9秒前
10秒前
坚定的白云完成签到,获得积分10
18秒前
笨笨盈完成签到,获得积分10
48秒前
云舒发布了新的文献求助50
54秒前
PMA完成签到,获得积分10
58秒前
聪明的煎蛋完成签到,获得积分10
1分钟前
1分钟前
TZL发布了新的文献求助10
1分钟前
充电宝的应助被TZL采纳,获得10
1分钟前
眼睛大淇完成签到,获得积分10
1分钟前
1分钟前
dida完成签到,获得积分10
1分钟前
惜缘完成签到 ,获得积分10
1分钟前
小肚黄完成签到 ,获得积分10
1分钟前
成就小蜜蜂完成签到 ,获得积分10
2分钟前
等待的依波完成签到,获得积分10
2分钟前
忧郁依柔完成签到,获得积分10
2分钟前
落后的雨筠完成签到,获得积分10
2分钟前
懦弱的念烟完成签到,获得积分10
3分钟前
3分钟前
清脆乘云完成签到,获得积分10
3分钟前
3分钟前
健康的紫文完成签到,获得积分10
3分钟前
搞怪的盛男完成签到,获得积分10
3分钟前
渡人舟的应助被科研通管家采纳,获得10
4分钟前
伶俐小懒猪完成签到,获得积分10
4分钟前
4分钟前
4分钟前
温暖的岂愈完成签到,获得积分10
4分钟前
辛勤的晓兰完成签到,获得积分10
4分钟前
风趣的雨莲完成签到,获得积分10
5分钟前
5分钟前
危机的冬瓜完成签到,获得积分10
5分钟前
受伤青丝完成签到,获得积分10
5分钟前
大意的山水完成签到,获得积分10
5分钟前
fishss完成签到 ,获得积分0
5分钟前
一只小喵完成签到,获得积分10
6分钟前
wwe完成签到,获得积分10
6分钟前
6分钟前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
Computational Chemical Reaction Engineering: Modeling, Simulation, and Design with MATLAB 600
Organizational Behavior 510
Management and the Arts 510
A Will for the Machine: Computerization, Automation, and the Arts in South Africa 400
Decentring Leadership 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7809602
求助须知:如何正确求助?哪些是违规求助? 9341782
关于积分的说明 20508504
捐赠科研通 7402337
什么是DOI,文献DOI怎么找? 3329166
关于科研通互助平台的介绍 2475934
邀请新用户注册赠送积分活动 2347920